Selected article for: "community structure and microbial community"

Title: RESEARCH COMMUNICATIONS OF THE 28th ECVIM-CA CONGRESS
  • Document date: 2018_12_19
  • ID: r79h9yzz_56
    Snippet: The pathogenesis of canine inflammatory bowel disease (IBD) likely involves complex interaction between the mucosal immune system and the intestinal microbiota. While one study compared the intestinal microbiota of dogs with IBD and food‐responsive diarrhea before and after treatment, there are no studies reporting changes in microbial community structure following glucocorticoid therapy. The objective of this study was to evaluate the effects .....
    Document: The pathogenesis of canine inflammatory bowel disease (IBD) likely involves complex interaction between the mucosal immune system and the intestinal microbiota. While one study compared the intestinal microbiota of dogs with IBD and food‐responsive diarrhea before and after treatment, there are no studies reporting changes in microbial community structure following glucocorticoid therapy. The objective of this study was to evaluate the effects of oral prednisone on the spatial distribution of mucosal bacteria in IBD dogs.

    Search related documents:
    Co phrase search for related documents
    • bowel disease and microbial community: 1
    • bowel disease and microbial community structure: 1
    • bowel disease and mucosal bacteria: 1, 2, 3, 4, 5
    • bowel disease and mucosal immune system: 1, 2
    • bowel disease and spatial distribution: 1
    • bowel disease and study objective: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • canine IBD inflammatory bowel disease and mucosal bacteria: 1
    • canine IBD inflammatory bowel disease and spatial distribution: 1
    • canine IBD inflammatory bowel disease and study objective: 1, 2
    • complex interaction and oral prednisone: 1
    • complex interaction and study objective: 1, 2, 3
    • glucocorticoid therapy and study objective: 1, 2, 3
    • IBD inflammatory bowel disease and mucosal bacteria: 1, 2, 3, 4, 5
    • IBD inflammatory bowel disease and mucosal immune system: 1
    • IBD inflammatory bowel disease and spatial distribution: 1
    • IBD inflammatory bowel disease and study objective: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • immune system and microbial community: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • immune system and mucosal bacteria: 1, 2, 3, 4
    • immune system and mucosal immune system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25